CION Cancer Clinics
MSH2 and your risk of urinary tract cancer | CION Cancer Clinics
Among the Lynch syndrome genes, MSH2 carries the clearest raised risk of cancer in the urinary tract, mainly in the kidney's drainage system and the ureter. Most carriers never develop it. The sign to watch for is blood in the urine, often without pain. This page explains which parts are at risk, how they are watched, and what a urine test can and cannot tell you. At CION Cancer Clinics, our oncologists explain what a gene result means for you and your family, and plan the checks that follow.
On this page
- Does an MSH2 fault raise the risk of urinary tract cancer?
- Which parts of the urinary tract are at risk?
- What does urinary tract surveillance involve?
- What do the urinary tract terms mean?
- What a urine test can and cannot do
- What this page cannot tell you
- Four things carriers say about the urinary tract, and what is true
- Common questions about MSH2 and the urinary tract
The short answer
Does an MSH2 fault raise the risk of urinary tract cancer?
Yes. Of all the Lynch syndrome genes, MSH2 carries the clearest raised risk of cancer in the urinary tract. The risk sits mainly in the lining of the kidney's drainage system and the ureter, the tube that carries urine down to the bladder. The bladder itself is affected less often. Most MSH2 carriers never develop any of these cancers.
The sign that matters most
The usual first sign is blood in the urine. It is often painless and may come and go, which is exactly why people ignore it. Urine may look pink, red or the colour of tea. For an MSH2 carrier, any episode should be reported to a doctor within days, even if it clears up on its own.
Why it matters when drawing the family tree
A relative's old diagnosis of kidney cancer may really have been a cancer of the kidney's drainage lining, which is a Lynch cancer. Asking exactly which part of the kidney was involved can change how your family history is read. Some studies also suggest the risk is higher in men than in women.
Blood in the urine has many simple causes. For a carrier it still needs a proper check.Part by part
Which parts of the urinary tract are at risk?
The raised risk follows the inner lining that urine touches, not the kidney tissue that makes urine.
Kidney drainage system
The funnel inside each kidney, called the renal pelvis, collects urine before it leaves. Its lining is one of the main sites of raised risk in MSH2 carriers.
Ureter
The narrow tube from each kidney to the bladder. It shares the same lining and the same raised risk. Growths here can block urine flow and cause a dull ache in the side.
Bladder
The risk is raised to a smaller degree. Smoking adds to it considerably, so stopping smoking matters even more for carriers.
Kidney tissue itself
The common type of kidney cancer, which starts in the tissue that filters blood, is not clearly part of the Lynch pattern.
Ask the team to clarify
- Which part of the kidney was involved
- What the pathology report called it
Not sure whether this applies to you?
Ask an oncologistHow it is watched
What does urinary tract surveillance involve?
A yearly urine test
Many guidelines suggest considering a simple urine test once a year from the thirties, especially when a relative had a urinary tract cancer. It looks for hidden blood.
A repeat if something shows
A single trace of blood is often from infection, a stone or exercise. The test is repeated, and infection is treated first if it is present.
Referral to a urologist
If blood persists, a urologist looks further. That usually means a scan of the kidneys and ureters and a camera test of the bladder.
Reporting symptoms in between
The yearly test is only a snapshot. Visible blood, a new ache in the side or a change in passing urine should be reported without waiting.
On your report
What do the urinary tract terms mean?
- Urothelium
- The lining of the whole urinary tract, from the kidney's drainage system down to the bladder.
- Upper tract urothelial cancer
- Cancer of that lining in the kidney's drainage system or ureter. This is the one most linked to MSH2.
- Renal pelvis
- The funnel inside the kidney that collects urine before it flows into the ureter.
- Urinalysis
- A simple urine test, often a dipstick, that looks for hidden blood, infection and protein.
- Urine cytology
- A laboratory look at cells in the urine for any that appear abnormal. It can miss small growths.
- Cystoscopy
- A thin camera passed into the bladder to look directly at its lining.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
What a urine test can and cannot do
Being straight with you
What this page cannot tell you
It cannot put a number on your own urinary tract risk. Published figures vary widely between studies, and few include Indian families. Your counsellor will weigh your sex, your age, your smoking history and any urinary cancers in your family before advising you.
It cannot say whether screening will help you
Studies of urine screening in Lynch syndrome are small. Guidelines offer it as something to consider, not as a firm rule. Your team may decide it is worthwhile, or that careful attention to symptoms is enough.
Who this does not apply to
Carriers of MLH1, MSH6 or PMS2 faults have a lower urinary tract risk, so this page mainly concerns MSH2 families. People with a variant of uncertain significance should not follow it either. What your specific variant means is a question for the counsellor who ordered the test. Tumour testing of an existing bladder or kidney cancer to guide treatment belongs with targeted therapy.
Commonly believed
Four things carriers say about the urinary tract, and what is true
Urinary tract cancers often cause no pain at first. Painless blood in the urine is the classic early sign, which is why it should never be ignored.
Dark yellow urine can come from heat. Pink, red or tea-coloured urine can mean blood. For an MSH2 carrier, that needs a urine test, not only more water.
Smoking is a big cause, but MSH2 carriers have a raised risk even if they have never smoked. Stopping smoking still lowers the added risk.
A yearly test is a snapshot. New symptoms between tests should be reported straight away rather than saved for the next appointment.
Questions we are asked
Common questions about MSH2 and the urinary tract
Why is MSH2 linked to urinary tract cancer more than other Lynch genes?
The reason is not fully understood. What is clear from large family studies is that urinary tract cancers turn up more often in MSH2 families than in MLH1, MSH6 or PMS2 families. That is why urine checks are discussed mainly with MSH2 carriers.
At what age should urine checks start?
Guidelines that suggest them usually point to the thirties, especially if a relative had a urinary tract cancer. The exact start, and whether to do them at all, is a decision made with your counsellor based on your family history.
I saw blood in my urine once and it went away. Should I worry?
Do not panic, but do not ignore it. Infection and stones are common causes. As an MSH2 carrier, you should still see a doctor within days, mention the gene, and ask for a urine test. If the blood returns, a referral to a urologist is usual.
Is a CT scan every year a better check?
Not as routine screening. Repeated scans add radiation and often find harmless things that lead to more tests. Scans are used when a urine test or a symptom gives a reason to look. Your urologist will decide which scan fits.
Does drinking more water lower the risk?
There is no good evidence that it lowers the Lynch-related risk. Staying hydrated is sensible for general health and makes urine easier to read. The steps that matter most are not smoking and reporting blood in the urine promptly.
Can the urinary tract risk be removed with surgery?
No. Unlike the womb and ovaries, the kidneys and bladder are not removed to lower risk. The plan relies on awareness, urine checks where advised, and quick investigation of any symptom.
My father had kidney cancer. Does that count as a Lynch cancer?
It depends on where it started. A cancer of the kidney's drainage lining is a Lynch cancer. The common type from the kidney's filtering tissue usually is not. If you can find the old pathology report, bring it to your counsellor.
Who should I see about urinary tract checks?
Start with the genetic counsellor who manages your Lynch plan. They can add urine checks to your schedule and refer you to a urologist when needed. Call the CION helpline if you are not sure where to begin.
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- GeneReviews (NCBI) — Lynch Syndrome
- National Cancer Institute — Genetics of Colorectal Cancer (PDQ)
- National Cancer Institute — Genetics of Kidney Cancer (Renal Cell Cancer) (PDQ)
- MedlinePlus Genetics — MSH2 gene
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Noticed blood in your urine and carry MSH2?
Tell us your gene result and what you noticed, and we will help you get it checked by the right specialist. One helpline serves every CION centre.